Moreover, AXL activity can promote the lateral activation of MET in RCC through the steroid receptor coactivator (Src) tyrosine kinase, a downstream signal transducer and regulator of RTKs in the intracellular domain [30]. This evidence concerns the gene MET and renal cell carcinoma.